nach oben

Erschienen in:

16.07.2020 | Neurology and Preclinical Neurological Studies - Original Article

The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease

verfasst von: Elmar H. Pinkhardt, Yin Ding, Samantha Slotnick, Jan Kassubek, Albert C. Ludolph, Sofya Glazman, Ivan Selesnick, Ivan Bodis-Wollner

Erschienen in: Journal of Neural Transmission | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Foveal structure that is specified by the thickness, depth and the overall shape of the fovea is a promising tool to qualify and quantify retinal pathology in Parkinson’s disease. To determine the model variable that is best suited for discriminating Parkinson’s disease eyes from those of healthy controls and to assess correlations between impaired contrast sensitivity and foveal shape we characterized the fovea in 48 Parkinson’s disease patients and 45 control subjects by optical coherence tomography (OCT). The model quantifies structural changes in the fovea of Parkinson’s disease patients that are correlated with a decline in contrast sensitivity. Retinal foveal remodeling may serve as a parameter for vision deficits in Parkinson’s disease. Whether foveal remodeling reflects dopaminergic driven pathology or rather both dopaminergic and non-dopaminergic pathology has to be investigated in longitudinal studies.

Adam CR, Shrier E, Ding Y et al (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33:137–142CrossRef

Bhaskar PA, Vanchilingam S, Bhaskar EA et al (1986) Effect of L-dopa on visual evoked potential in patients with Parkinson’s disease. Neurology 36:1119–1121CrossRef

Bodis-Wollner I (1972) Visual acuity and contrast sensitivity in patients with cerebral lesions. Science 178:769–771. https://doi.org/10.1126/science.178.4062.769 CrossRefPubMed

Bodis-Wollner I, Yahr MD (1978) Measurements of visual evoked potentials in Parkinson’s disease. Brain 101:661–671CrossRef

Bodis-Wollner I, Yahr MD, Mylin L, Thornton J (1982) Dopaminergic deficiency and delayed visual evoked potentials in humans. Ann Neurol 11:478–483CrossRef

Bodis-Wollner I, Marx MS, Mitra S et al (1987) Visual dysfunction in Parkinson’s disease. Loss in spatiotemporal contrast sensitivity. Brain 110(Pt 6):1675–1698CrossRef

Bodis-Wollner I, Miri S, Glazman S (2013) Venturing into the no-man’s land of the retina in Parkinson’s disease. Mov Disord 29:15–22CrossRef

Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) Alpha-synuclein in the inner retina in Parkinson disease. Ann Neurol 75(6):964–966CrossRef

Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB (1987) Effect of levodopa treatment on contrast sensitivity in Parkinson’s disease. Ann Neurol 22:365–369CrossRef

Buttner T, Kuhn W, Muller T et al (1996) Chromatic and achromatic visual evoked potentials in Parkinson’s disease. Electroencephalogr Clin Neurophysiol 100:443–447CrossRef

Chorostecki J, Seraji-Bozorgzad N, Shah A et al (2015) Characterization of retinal architecture in Parkinson’s disease. J Neurol Sci 355:44–48. https://doi.org/10.1016/j.jns.2015.05.007 CrossRefPubMed

Delalande I, Hache JC, Forzy G et al (1998) Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson’s disease and multiple system atrophy? Mov Disord 13:446–452CrossRef

Ding Y, Spund B, Glazman S et al (2014) Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. J Neural Transm 121:1367–1376CrossRef

Firsov ML, Astakhova LA (2016) The role of dopamine in controlling retinal photoreceptor function in vertebrates. Neurosci Behav Physiol 46:138–145. https://doi.org/10.1007/s11055-015-0210-9 CrossRef

Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752CrossRef

Guo L, Normando EM, Shah PA et al (2018) Oculo-visual abnormalities in Parkinson’s disease: possible value as biomarkers. Mov Disord 33:1390–1406. https://doi.org/10.1002/mds.27454 CrossRefPubMed

Hajee ME, March WF, Lazzaro DR et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737–741CrossRef

Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed

Hasbi A, O’Dowd BF, George SR (2011) Dopamine D1–D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain 4:26. https://doi.org/10.1186/1756-6606-4-26 CrossRefPubMedPubMedCentral

Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vis Res 34:2629–2638CrossRef

Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797CrossRef

Müller A-K, Blasberg C, Südmeyer M et al (2014) Photoreceptor layer thinning in parkinsonian syndromes. Mov Disord 29:1222–1223CrossRef

Nieves-Moreno M, Martínez-de-la-Casa JM, Morales-Fernández L et al (2018) Impacts of age and sex on retinal layer thicknesses measured by spectral domain optical coherence tomography with Spectralis. PLoS ONE 13:1–9. https://doi.org/10.1371/journal.pone.0194169 CrossRef

Nightingale S, Mitchell KW, Howe JW (1986) Visual evoked cortical potentials and pattern electroretinograms in Parkinson’s disease and control subjects. J Neurol Neurosurg Psychiatry 49:1280–1287CrossRef

Ridder A, Müller MLTM, Kotagal V et al (2017) Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord 34:15–19CrossRef

Schneider M, Müller H-P, Lauda F et al (2014) Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm 121:41–47CrossRef

Slotnick S, Ding Y, Glazman S et al (2015) A novel retinal biomarker for Parkinson’s disease: quantifying the foveal pit with optical coherence tomography. Mov Disord 30(12):1692–1695CrossRef

Spund B, Ding Y, Liu T et al (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm 120(5):745–753CrossRef

Stanzione P, Bodis-Wollner I, Pierantozzi M et al (1999) A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson’s disease pattern electroretinogram alterations. Clin Neurophysiol 110:82–85CrossRef

Tagliati M, Bodis-Wollner I, Yahr MD (1996) The pattern electroretinogram in Parkinson’s disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 100:1–11CrossRef

Tan JMM, Wong ESP, Lim K-L (2009) Protein misfolding and aggregation in Parkinson’s disease. Antioxid Redox Signal 11:2119–2134. https://doi.org/10.1089/ars.2009.2490 CrossRefPubMed

Terry L, Cassels N, Lu K et al (2016) Using spectral domain optical coherence tomography : evaluation of inter-session repeatability and agreement between devices. PLoS ONE. https://doi.org/10.1371/journal.pone.0162001 CrossRefPubMedPubMedCentral

Turcano P, Chen JJ, Bureau BL, Savica R (2018) Early ophthalmologic features of Parkinson’s disease: a review of preceding clinical and diagnostic markers. J Neurol. https://doi.org/10.1007/s00415-018-9051-0 CrossRefPubMed

Watson AB, Barlow HB, Robson JG (1983) What does the eye see best? Nature 302:419–422. https://doi.org/10.1038/302419a0 CrossRefPubMed

Young JB, Godara P, Williams V et al (2019) Assessing retinal structure in patients with Parkinson disease. J Neurol Neurophysiol. https://doi.org/10.4172/2155-9562.1000485 CrossRefPubMedPubMedCentral

Titel: The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease
verfasst von: Elmar H. Pinkhardt
Yin Ding
Samantha Slotnick
Jan Kassubek
Albert C. Ludolph
Sofya Glazman
Ivan Selesnick
Ivan Bodis-Wollner
Publikationsdatum: 16.07.2020
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 9/2020
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-020-02224-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2020

The cerebral blood flow deficits in Parkinson’s disease with mild cognitive impairment using arterial spin labeling MRI

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses

Effects of intrathecal baclofen therapy in subjects with disorders of consciousness: a reappraisal

Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis

Prefrontal cortex hypoactivity distinguishes severe from mild-to-moderate social anxiety as revealed by a palm-sized near-infrared spectroscopy system

Genome-wide methylation association with current suicidal ideation in schizophrenia

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie